PATENT CLAIM ANALYSIS

Application Number: 16199905
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "114000"]

Abstract:
S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage.

Claim (Index 6):
A method according to  claim 2  wherein said subject is at risk of cardiac side effects or heart failure.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 98.0
- Lexical Diversity: 1.20833
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12655049', '14732013', '14322722', '15986992', '15534929']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7804435814355626
- 35 USC 102 Novelty (BERT): 0.5419343880555084
- Combined Prediction Score: 0.7565926620975572
- Mean Citation Score: 288.4315200000001
- Max Citation Score: 407.60342
- Similarity Product: 213.94837051501395

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test